Cite
HARVARD Citation
Honeyborne, I. et al. (2016). Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy. BMC medicine. 14 (1), pp. 1-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Honeyborne, I. et al. (2016). Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy. BMC medicine. 14 (1), pp. 1-13. [Online].